Oncternal Therapeutics, Inc. earnings per share and revenue

ONCT earnings per share for the last quarter are -3.11 USD whereas the estimation was -3.08 USD which accounts for -0.81% surprise. Company revenue for the same period amounts to 297.00 k USD despite the estimated figure of 128.00 k USD. Estimated earnings per share for the next quarter are -2.88 USD, and revenue is expected to reach 183.33 k USD. Also watch annual changes over time to get a bigger picture of ONCT earnings per share and revenue dynamics.